Skip to main content
Retour
Watch Compare

Curaleaf Holdings, Inc.

Qualité des données : 100%
CURLF
OTC Manufacturing Chemicals
2,64 €
▲ 0,01 € (0,38%)
6 months return
—
Momentum
Neutral
ROE
-28,57%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-5,56%
Earnings (1Y)N/A
FCF Growth (3Y)175,07%

Qualité

Return on Equity
-28,57%
Au-dessus de la moyenne du secteur (-54,68%)
ROIC0,79%
Net Margin-18,22%
Op. Margin2,01%

Sécurité

Debt / Equity
0,73
Au-dessus de la moyenne du secteur (0,30)
Current Ratio1,52
Interest Coverage0,48

Valorisation

PE (TTM|NTM)
-7,80 | -10,04
En dessous de la moyenne du secteur (-1,50)
P/B Ratio2,38
EV/EBITDA10,59
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Generating 74,27 M in free cash flow
Capital efficient — spends only 5,00% of revenue on capex
ROIC of 0,79% — low return on invested capital
Interest coverage of 0,48× — tight debt servicing

Price History

Tendances Financières

Objectif de Cours des Analystes

2 analystes
Buy
+70.5%
upside to target
Actuel
2,64 €
Consensus Target
4,50 €
4,00 €
Bas
5,00 €
Haut
Prévisions
P/E Prévisionnel
-10,04
BPA Prévisionnel
-0,26 €
CA Est.
1,44 B

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,09 € · Rev Est: 317,05 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,08 € -0,06 € -0,06 € -0,05 € — —
Estimate -0,07 € -0,07 € -0,08 € -0,09 € -0,09 € -0,08 €
Surprise -7,43% +10,71% +20,63% +44,44% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) -5,56% Revenue Growth (3Y) -2,96%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -28,57% · Net Margin: -18,22%
Revenue (TTM) 1,27 B Net Income (TTM) -231,07 M
ROE -28,57% ROA -7,98%
Gross Margin 49,76% Operating Margin 2,01%
Net Margin -18,22% Free Cash Flow (TTM) 74,27 M
ROIC 0,79% FCF Growth (3Y) 175,07%

Safety

D/E: 0,73 · Current: 1,52
Debt / Equity 0,73 Current Ratio 1,52
Interest Coverage 0,48 Asset Turnover 0,44
Working Capital 154,31 M Tangible Book Value -889,88 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -7,80 · EV/EBITDA: 10,59
P/E Ratio -7,80 Forward P/E -10,04
P/B Ratio 2,38 P/S Ratio 1,42
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 10,59 Fwd EV/EBITDA N/A
Forward P/S 1,25 Fwd Earnings Yield N/A
FCF Yield 4,12%
Market Cap 1,80 B Enterprise Value 2,35 B

Per Share

EPS: -0,35 · FCF/Share: 0,10
EPS (Diluted TTM) -0,35 Revenue / Share 1,64
FCF / Share 0,10 OCF / Share 0,18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -32,14% · CapEx/Rev: 5,00%
CapEx / Revenue 5,00% FCF Conversion -32,14%
SBC-Adj. FCF 38,53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 1,27 B 1,34 B 1,35 B 1,34 B
Net Income -231,07 M -215,42 M -281,20 M -370,10 M
EPS (Diluted) -0,35 -0,32 -0,39 -0,52
Gross Profit 631,02 M 639,25 M 614,45 M 579,03 M
Operating Income 25,45 M 20,20 M 42,88 M -12,37 M
EBITDA — — — —
R&D Expenses 805 000,0 — — —
SG&A Expenses 428,44 M 421,53 M 414,77 M 447,54 M
D&A 196,61 M 233,23 M 195,88 M 163,77 M
Interest Expense 53,52 M 53,17 M — —
Income Tax 123,69 M 98,59 M 114,59 M 150,50 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 2,85 B 2,95 B 3,10 B 3,40 B
Total Liabilities 2,01 B 1,96 B 1,93 B 2,00 B
Shareholders' Equity 756,35 M 861,21 M 1,05 B 1,28 B
Total Debt 548,65 M 568,62 M 587,77 M 622,82 M
Cash & Equivalents — — — 163,18 M
Current Assets 448,62 M 429,68 M 418,60 M 605,33 M
Current Liabilities 294,31 M 387,93 M 494,03 M 491,08 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -7,8 -1,5
P/B 2,4 1,6
ROE % -28,6 -54,7
Net Margin % -18,2 -41,5
Rev Growth 5Y % — 1,7
D/E 0,7 0,3

ETFs Holding This Stock
MSOS logo MSOS AdvisorShares Pure US Cannabis ETF
3,54% weight